Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas
Clinical trial NCT03179930 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03179930
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-07
- Primary completion
- 2027-06-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.